Boston et New-York, 24 au 25 octobre 2018
TEMISIS, one of PAT’s subsidiary, is one of three finalists for the Prix Galien MedStartUp 2018. TEMISIS is nominated in the Best Collaboration with Academia Leading to a Breakthrough Solution.
Boston et New-York, 24 au 25 octobre 2018
TEMISIS, one of PAT’s subsidiary, is one of three finalists for the Prix Galien MedStartUp 2018. TEMISIS is nominated in the Best Collaboration with Academia Leading to a Breakthrough Solution.
